1 |
Suárez-rivero JM, López-pérez J, Muela-zarzuela I, Pastor-maldonado C, Cilleros-holgado P, Gómez-fernández D, Álvarez-córdoba M, Munuera-cabeza M, Talaverón-rey M, Povea-cabello S, Suárez-carrillo A, Piñero-pérez R, Reche-lópez D, Romero-domínguez JM, Sánchez-alcázar JA. Neurodegeneration, Mitochondria, and Antibiotics. Metabolites 2023;13:416. [DOI: 10.3390/metabo13030416] [Reference Citation Analysis]
|
2 |
Ailioaie LM, Ailioaie C, Litscher G. Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine? Pharmaceutics 2023;15:916. [DOI: 10.3390/pharmaceutics15030916] [Reference Citation Analysis]
|
3 |
Burtscher J, Pepe G, Maharjan N, Riguet N, Di Pardo A, Maglione V, Millet GP. Sphingolipids and impaired hypoxic stress responses in Huntington disease. Prog Lipid Res 2023;90:101224. [PMID: 36898481 DOI: 10.1016/j.plipres.2023.101224] [Reference Citation Analysis]
|
4 |
Burtscher J, Soltany A, Visavadiya NP, Burtscher M, Millet GP, Khoramipour K, Khamoui AV. Mitochondrial stress and mitokines in aging. Aging Cell 2023;22:e13770. [PMID: 36642986 DOI: 10.1111/acel.13770] [Reference Citation Analysis]
|
5 |
Luo H, Xu J, Huang D, Chen Y, Liu Y, Li Y, Chen H. Mitochondrial dysfunction of induced pluripotent stem cells-based neurodegenerative disease modeling and therapeutic strategy. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1030390] [Reference Citation Analysis]
|